List view / Grid view

Issue 6 2020

Filter the results

 

article

Pioneering a full-ecosystem microbiota approach to improve survival outcomes in life-threatening diseases

16 December 2020 | By

The human gut contains the largest ecosystem of microbial species having complex host-microbiome interactive networks that contribute to our physiology and regulate our immune system. An imbalance in this host-microbiome interaction is associated with disease and the ability to restore or stabilise the network by introducing a rich and diverse…

article

Current innovations in the vaccine pipeline

16 December 2020 | By , , ,

As the global COVID-19 response continues, so does the rapidly expanding pipeline for a novel COVID-19 vaccine. Here, experts from Avalere Health outline ongoing US and global vaccine development efforts, including the role of public-private partnerships in accelerating vaccine development. They will also focus on the broader context of respiratory…

article

Pharmaceutical bottle packaging – the quest for zero defects and data integrity

16 December 2020 | By ,

This article shares the results from an evaluation of a novel thermal imaging technology that took place before the initial implementation in a Pfizer manufacturing facility. The manuscript describes the technology and reviews the extensive process used to challenge its inspection capabilities through field testing. Finally, the potential benefits of…

article

Innovations in analytical science: development of rapid, high-throughput glycoanalytics for biopharmaceuticals

16 December 2020 | By , , , , , , , ,

Researchers have developed a novel high-throughput method for the detection of glycans in purified biopharmaceutical samples. In this article, Victoria Smith, Lewis Wharram and Stuart Jamieson discuss their innovative approach and the implications for safety and potency assurance in biopharmaceuticals.

article

New opportunities for the global API market

15 December 2020 | By

Active pharmaceutical ingredients (APIs) are primary components in the manufacture of drugs, yet this global market experiences numerous challenges. Regulatory pressure, pricing arbitrages, a shift to digital manufacturing and patents for blockbuster drugs are chief among them, but the COVID-19 pandemic added a further hurdle as governments globally decided to…

article

Improved in vitro renal tubular drug transport modelling to meet regulatory and development cost challenges

15 December 2020 | By

Due to the high costs associated with drug discovery and the clinical demand for effective drugs, in vitro human cell-based kidney models using renal proximal tubule epithelia are becoming popular tools for early-stage testing. It is increasingly more important that in vitro models of renal drug transport are physiologically representative…

article

Recent improvements in deep ultra-violet fluorescence devices for cleaning verification

14 December 2020 | By ,

Since their debut, the range of applications for which deep ultra-violet (DUV) handheld devices are used in the pharmaceutical setting continues to grow. For pharmaceutical or biopharmaceutical cleaning verification, there is a requirement for a versatile and adaptive analytical and imaging device to demonstrate and document cleaning cycles. Here, Krishnakumar…